	债务		日
Acadia Pharmaceuticals	USD 54.81M	1.48M	2025-09
Agios Pharmaceuticals	USD 40.21M	4.31M	2025-12
Alnylam Pharmaceuticals	USD 1.28B	30.06M	2025-12
BioCryst Pharmaceuticals	USD 828.6M	510K	2024-12
BioMarin Pharmaceutical	USD 605.86M	1.62M	2025-12
Esperion Therapeutics	USD 262.92M	1.76M	2024-09
Immunic	USD 0	0	2024-06
Insmed	USD 727.89M	163.33M	2025-12
Ionis Pharmaceuticals	USD 2.34B	9.5M	2026-03
Karyopharm Therapeutics	USD 299.23M	35.14M	2025-12
Kyowa Hakko Kirin	JPY 28.75B	5.04B	2024-12
MacroGenics	USD 37.01M	238K	2025-09
Moderna	USD 1.31B	571M	2025-12
Neurocrine Biosciences	USD 415.3M	13.1M	2025-12
PTC Therapeutics	USD 2.71B	2.42B	2025-12
Puma Biotechnology	USD 89.06M	55.07M	2024-06
Regeneron Pharmaceuticals	USD 2.71B	300K	2026-03
Sarepta Therapeutics	USD 1.25B	103.69M	2025-09
Ultragenyx Pharmaceutical	USD 36M	2.17M	2025-12
Vertex Pharmaceuticals	USD 2.03B	195.7M	2025-12
Xoma	USD 120.79M	3.27M	2024-06